Analysis of the metabolism of ketone bodies and lactate by gastrointestinal tumour cells in vitro;Experimentelle Untersuchungen zur Verstoffwechselung von Ketonkörpern und Laktat durch Tumorzellen des Gastrointestinaltrakts

Aktuelle Ernahrungsmedizin

Volumn 39, Issue 1, 2014, Pages 51-59

  Otto, C ^a   Klingelhoffer C ^a   Biggemann, L ^a   Melkus, G ^b,c   Morchel P ^b   Jurgens C ^d   Gahn, S ^a   Kammerer U ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

glucose metabolism; hypoxia; ketogenic diet; ketone bodies; tumour growth

Indexed keywords

EID: 84893976552     PISSN: 03410501     EISSN: 14389916     Source Type: Journal    
DOI: 10.1055/s-0033-1360007     Document Type: Article

References (53)

1. Tennant D. A., Durán R. V., Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat Rev Cancer: 2010; 10 267 277
2. Hübner J., Marienfeld S., Abbenhardt C. et al. Wie sinnvoll sind "Krebsdiäten? Eine kritische Analyse als Grundlage für die ärztliche Beratung. Deutsche Med Wochenschrift: 2012; 137 2417 2422
3. Hübner J., Löser C., Stoll C. Vorstellungen zur Therapie von Malignomen mit Krebsdiäten. Onkologe: 2013; 19 108 116
4. Bonuccelli G., Tsirigos A., Whitaker-Menezes D. et al. Ketones and lactate fuel tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle: 2010; 9 3506 3514
5. Magee B. A., Potezny N., Rofe A. M. et al. The inhibition of malignant cell growth by ketone bodies. Aust J Exp Biol Med Sci: 1979; 57 529 539
6. Tisdale M. J., Brennan R. A. Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissues. Br J Cancer: 1983; 47 293 297
7. Sawai M., Yashiro M., Nishiguchi Y. et al. Growth-inhibitory effects of the ketone body, monoacetoacetin, on human gastric cancer cells with succinyl-CoA: 3-oxoacid CoA-transferase (SCOT) deficiency. Anticancer Res: 2004; 24 2213 2217
8. Skinner R., Trujillo A., Ma X. et al. Ketone bodies inhibit the viability of human neuroblastoma cells. J Pediatr Surg: 2009; 44 212 216
9. Fine E. J., Miller A., Quadros E. V. et al. Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2. Cancer Cell Int: 2009; 9 14
10. Vaupel P., Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev: 2007; 26 225 239
11. 2 availability on human cancer. Nat Rev Cancer: 2008; 8 967 975
12. Solaini G., Baracca A., Lenaz G. et al. Hypoxia and mitochondrial oxidative metabolism. Biochim Biophys Acta: 2010; 1797 1171 1177
13. Kallinowski F., Schlenger K. H., Runkel S. et al. Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Res: 1989; 49 3759 3764
14. Cahill G. F. Jr. Starvation in man. N Engl J Med: 1970; 282 668 675
15. Veech R. L. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids: 2004; 70 309 319
16. McGarry J. D., Forster D. W. Regulation of hepatic fatty acid oxidation and ketone body production. Ann Rev Biochem: 1980; 49 395 420
17. Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev: 1999; 15 412 426
18. VanItallie T. B., Nufert T. H. Ketones: metabolism's ugly duckling. Nutr Rev: 2003; 61 327 341
19. Longo N., Fukao T., Singh R. et al. Succinyl-CoA:3-ketoacid transferase (SCOT) deficiency in a new patient homozygous for an R217X mutation. J Inherit Metab Dis: 2004; 27 691 692
20. Racker E. History of the Pasteur effect and its pathobiology. Mol Cell Biochem: 1974; 5 17 23
21. Warburg O., Minami S. Versuche an überlebendem Karzinomgewebe. Klinische Wochenschrift: 1923; 17 776 777
22. Sonveaux P., Végran F., Schroeder T. et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest: 2008; 118 3930 3942
23. Vollmers H. P., Stulle K., Dämmrich J. et al. Characterization of four new gastric cancer cell lines. Virchows Arch B Cell Pathol Incl Mol Pathol: 1993; 63 335 343
24. Pfaffl M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res: 2001; 29 e45
25. Jurowich C. F., Rikkala P. R., Thalheimer A. et al. Duodenal-Jejunal Bypass Improves Glycemia and Decreases SGLT1-Mediated Glucose Absorption in Rats with Streptozotocin-Induced Type 2 Diabetes. Ann Surg: 2013; 258 89 97
26. + rat T cells with immunostimulatory properties. Transpl Immunol: 2012; 26 220 229
27. Otto C., Kämmerer U., Illert B. et al. Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. BMC Cancer: 2008; 8 122
28. Gruetter R. Automatic, localized in vivo adjustment of all first- and second-order shim coils. Magn Reson Med: 1993; 29 804 811
29. He Q., Shungu D. C., van Zijl P. C. et al. Single scan in vivo lactate editing with complete lipid and water suppression by selective multiple-quantumcoherence transfer (Sel-MQC) with application to tumors. J Magn Reson B: 1995; 106 203 211
30. Melkus G., Mörchel P., Behr V. C. et al. Sensitive J-coupled metabolite mapping using Sel-MQC with selective multi spin echo readout. Mag Reson Med: 2009; 62 880 887
31. Mörchel P., Melkus G., Yaromina A. et al. Correlating quantitative MR measurements of standardized tumor lines with histological parameters and tumor control dose. Radiother Oncol: 2010; 96 123 130
32. Gatenby R. A., Gillies R. J. Why do cancers have high aerobic glycolysis? Nat Rev Cancer: 2004; 4 891 899
33. Gatenby R. A., Smallbone K., Maini P. K. et al. Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Br J Cancer: 2007; 97 646 653
34. Wallace D. C. Mitochondria and cancer. Nat Rev Cancer: 2012; 12 685 698
35. Newsholme E. A. Carbohydrate metabolism in vivo: regulation of the blood glucose level. Clin Endocrinol Metab: 1976; 5 543 578
36. Walenta S., Mueller-Klieser W. F. Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol: 2004; 14 267 274
37. Walenta S., Wetterling M., Lehrke M. et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res: 2000; 60 916 921
38. Fischer K., Hoffmann P., Voelkl S. et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood: 2007; 109 3812 3819
39. Shime H., Yabu M., Akazawa T. et al. Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway. J Immunol: 2008; 180 7175 7183
40. Wilder R. High fat diets in epilepsy. Mayo Clin Bull: 1921; 2 307 308
41. Freeman J. M., Kossoff E. H., Hartman A. L. The ketogenic diet: one decade later. Pediatrics: 2007; 119 535 543
42. McNally M. A., Hartman A. L. Ketone bodies in epilepsy. J Neurochem: 2012; 121 28 35
43. Stafstrom C. E., Rho J. M. The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol: 2012; 3 59
44. Williamson J. R., Krebs H. A. Acetoacetate as fuel of respiration in the perfused rat heart. Biochem J: 1961; 80 540 547
45. Hanson R. W. Interrelationship of ketone body metabolism and glucose utilisation by adipose tissue in vitro. Arch Biochem Biophys: 1965; 109 98 103
46. Schmidt M., Pfetzer N., Schwab M. et al. Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial. Nutr Metab (Lond): 2011; 8 54
47. Fine E. J., Segal-Isaacson C. J., Feinman R. D. et al. Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients. Nutrition: 2012; 28 1028 1035
48. Klement R. J., Frobel T., Albers T. et al. A pilot case study on the impact of a self-prescribed ketogenic diet on biochemical parameters and running performance in healthy and physically active individuals. Nutrition and Medicine: 2012; 1 10
49. Collier G., O'Dea K. The effect of coingestion of fat on the glucose, insulin, and gastric inhibitory polypeptide responses to carbohydrate and protein. Am J Clin Nutr: 1983; 37 941 944
50. Kaaks R., Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc: 2001; 60 91 106
51. Holm E., Hagmüller E., Staedt U. et al. Substrate balances across colonic carcinomas in humans. Cancer Res: 1995; 55 1373 1378
52. Holm E., Kämmerer U. Fette und Kohlenhydrate in Ernä hrungskonzepten für Tumorpatienten. Aktuel Ernahrungsmed: 2011; 36 286 298
53. Klement R. J., Kämmerer U. Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab (Lond): 2011; 8 75